JPWO2019216294A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019216294A5
JPWO2019216294A5 JP2020518289A JP2020518289A JPWO2019216294A5 JP WO2019216294 A5 JPWO2019216294 A5 JP WO2019216294A5 JP 2020518289 A JP2020518289 A JP 2020518289A JP 2020518289 A JP2020518289 A JP 2020518289A JP WO2019216294 A5 JPWO2019216294 A5 JP WO2019216294A5
Authority
JP
Japan
Prior art keywords
methyl
pyridin
imidazo
trifluoromethyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020518289A
Other languages
English (en)
Japanese (ja)
Other versions
JP7235047B2 (ja
JPWO2019216294A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/018201 external-priority patent/WO2019216294A1/ja
Publication of JPWO2019216294A1 publication Critical patent/JPWO2019216294A1/ja
Publication of JPWO2019216294A5 publication Critical patent/JPWO2019216294A5/ja
Application granted granted Critical
Publication of JP7235047B2 publication Critical patent/JP7235047B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020518289A 2018-05-08 2019-05-07 アザベンゾイミダゾール化合物及び医薬 Active JP7235047B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018089867 2018-05-08
JP2018089867 2018-05-08
PCT/JP2019/018201 WO2019216294A1 (ja) 2018-05-08 2019-05-07 アザベンゾイミダゾール化合物及び医薬

Publications (3)

Publication Number Publication Date
JPWO2019216294A1 JPWO2019216294A1 (ja) 2021-05-13
JPWO2019216294A5 true JPWO2019216294A5 (https=) 2023-01-19
JP7235047B2 JP7235047B2 (ja) 2023-03-08

Family

ID=68467433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020518289A Active JP7235047B2 (ja) 2018-05-08 2019-05-07 アザベンゾイミダゾール化合物及び医薬

Country Status (35)

Country Link
US (1) US12319683B2 (https=)
EP (1) EP3792260B1 (https=)
JP (1) JP7235047B2 (https=)
KR (1) KR102819951B1 (https=)
CN (1) CN112368282B (https=)
AU (1) AU2019265134B2 (https=)
BR (1) BR112020022662A2 (https=)
CA (1) CA3099655A1 (https=)
CL (1) CL2020002868A1 (https=)
CO (1) CO2020013848A2 (https=)
DK (1) DK3792260T3 (https=)
EC (1) ECSP20078586A (https=)
ES (1) ES2992256T3 (https=)
FI (1) FI3792260T3 (https=)
HR (1) HRP20241414T1 (https=)
HU (1) HUE068695T2 (https=)
IL (1) IL278517B2 (https=)
LT (1) LT3792260T (https=)
MA (1) MA52587B1 (https=)
MD (1) MD3792260T2 (https=)
MX (1) MX2020011855A (https=)
MY (1) MY202833A (https=)
PE (1) PE20211384A1 (https=)
PH (1) PH12020551873A1 (https=)
PL (1) PL3792260T3 (https=)
PT (1) PT3792260T (https=)
RS (1) RS65996B1 (https=)
SA (1) SA520420487B1 (https=)
SG (1) SG11202011003TA (https=)
SI (1) SI3792260T1 (https=)
SM (1) SMT202400407T1 (https=)
TW (1) TWI868068B (https=)
UA (1) UA126774C2 (https=)
WO (1) WO2019216294A1 (https=)
ZA (1) ZA202007164B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2992256T3 (es) 2018-05-08 2024-12-11 Nippon Shinyaku Co Ltd Compuestos de azabencimidazol y producto farmacéutico
BR112022008571A2 (pt) 2019-11-13 2022-08-09 Nippon Shinyaku Co Ltd Composto de azabenzimidazol e medicamento
WO2021095805A1 (ja) * 2019-11-13 2021-05-20 日本新薬株式会社 機能性消化管障害及び口腔乾燥症の治療剤及び予防剤
CN118045050B (zh) * 2023-11-16 2025-06-10 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 一种头颈部放疗患者适用的缓解口腔干燥的组合物及其制备方法
WO2025153078A1 (zh) * 2024-01-17 2025-07-24 盛睿泽华医药科技(苏州)有限公司 可溶性环氧水解酶抑制剂及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571819A (en) 1994-11-22 1996-11-05 Sabb; Annmarie L. Imidazopyridines as muscarinic agents
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
UA73543C2 (uk) 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
TW200538095A (en) 2004-03-11 2005-12-01 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
EP1723142A1 (en) 2004-03-11 2006-11-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
EP1734820A4 (en) 2004-04-16 2008-01-23 Neurogen Corp Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
ES2274712B1 (es) * 2005-10-06 2008-03-01 Laboratorios Almirall S.A. Nuevos derivados imidazopiridina.
PT2054405E (pt) 2006-07-11 2013-12-24 Dae Woong Pharma Novos derivados de biaril benzoimidazol e composição farmacêutica que compreende os mesmos
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
GB0706168D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
MX2010007587A (es) 2008-01-24 2010-08-04 Ucb Pharma Sa Compuestos que comprenden un grupo ciclobutoxi.
WO2010130392A1 (de) 2009-05-11 2010-11-18 Ratiopharm Gmbh Desfesoterodin in form eines weinsäuresalzes
WO2011018894A1 (en) 2009-08-10 2011-02-17 Raqualia Pharma Inc. Pyrrolopyrimidine derivatives as potassium channel modulators
JP5667934B2 (ja) * 2010-06-28 2015-02-12 大日本住友製薬株式会社 新規2環性複素環化合物からなる医薬
TWI541243B (zh) 2010-09-10 2016-07-11 拜耳知識產權公司 經取代咪唑并嗒
CA2821834A1 (en) * 2010-12-17 2012-06-21 Bayer Intellectual Property Gmbh 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
JP2013545779A (ja) 2010-12-17 2013-12-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 過剰増殖性障害の治療におけるmps−1およびtkk阻害剤として使用するための6置換イミダゾピラジン
JP6038150B2 (ja) 2011-08-24 2016-12-07 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Nedd8活性化酵素阻害剤
JP2013237634A (ja) 2012-05-14 2013-11-28 Dainippon Sumitomo Pharma Co Ltd 縮環イミダゾロン誘導体
GB201302927D0 (en) 2013-02-20 2013-04-03 Cancer Therapeutics Crc Pty Ltd Compounds
TWI647227B (zh) 2013-02-28 2019-01-11 日商安斯泰來製藥股份有限公司 2-醯胺噻唑衍生物或其鹽
EA031866B1 (ru) 2014-06-06 2019-03-29 Астеллас Фарма Инк. Производное 2-ациламинотиазола или его соль
BR112017003901A2 (pt) 2014-08-26 2017-12-12 Astellas Pharma Inc derivado de 2-aminotiazola ou sal do mesmo
JP6680297B2 (ja) 2015-04-28 2020-04-15 アステラス製薬株式会社 経口投与用医薬組成物
WO2018112840A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
CN115504986B (zh) 2017-03-03 2024-05-14 江苏豪森药业集团有限公司 凋亡信号调节激酶抑制剂及其制备方法和应用
CA3085745A1 (en) 2017-12-21 2019-06-27 Kyorin Pharmaceutical Co., Ltd. An agent for treating nocturnal pollakiuria
WO2019189766A1 (ja) 2018-03-30 2019-10-03 持田製薬株式会社 新規ビアリールアミド誘導体
ES2992256T3 (es) 2018-05-08 2024-12-11 Nippon Shinyaku Co Ltd Compuestos de azabencimidazol y producto farmacéutico
TW202012415A (zh) 2018-05-08 2020-04-01 瑞典商阿斯特捷利康公司 化學化合物
WO2021095805A1 (ja) 2019-11-13 2021-05-20 日本新薬株式会社 機能性消化管障害及び口腔乾燥症の治療剤及び予防剤
BR112022008571A2 (pt) 2019-11-13 2022-08-09 Nippon Shinyaku Co Ltd Composto de azabenzimidazol e medicamento

Similar Documents

Publication Publication Date Title
JPWO2019216294A5 (https=)
US11795164B2 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
US12180193B2 (en) Accelerating fibrosarcoma protein degrading compounds and associated methods of use
US10253019B2 (en) Tank-binding kinase inhibitor compounds
US11304946B2 (en) 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
US10287266B2 (en) Compounds and compositions for inhibiting the activity of SHP2
AU2014291711B2 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
US11591311B2 (en) 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
US11524944B2 (en) 2-phenylpyrimidine-4-carboxamides as AHR inhibitors
US8802663B2 (en) Pyrazole oxadiazole derivatives as S1P1 agonists
JP2006503010A5 (https=)
CA3164832A1 (en) 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
JP2011515462A5 (https=)
JP2017515844A5 (https=)
CN107207489A (zh) 作为nadph氧化酶抑制剂的酰氨基噻二唑衍生物
HRP20241414T1 (hr) Azabenzimidazolski spojevi i farmaceutski proizvod
US20190388421A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
JP2021500332A5 (https=)
CN103237795B (zh) 经取代的噁二唑化合物及其作为s1p1激动剂的用途
US20240174683A1 (en) Map4k1 inhibitors
US8835470B2 (en) Mandelamide heterocyclic compounds
JP2024508817A (ja) B型肝炎ウイルス感染症の処置および予防のためのベンゾチアゾリルビシクロ[1.1.1]ペンタン誘導体
RU2020139649A (ru) Азабензимидазольные соединения и фармкомпозиция
JP2014040374A (ja) グリシントランスポーター阻害物質
JPWO2023046806A5 (https=)